News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,820 Results
Type
Article (39405)
Company Profile (248)
Press Release (653167)
Section
Business (204104)
Career Advice (2005)
Deals (35412)
Drug Delivery (93)
Drug Development (81022)
Employer Resources (169)
FDA (16135)
Job Trends (14830)
News (345032)
Policy (32483)
Tag
Academia (2538)
Alliances (49348)
Alzheimer's disease (1314)
Approvals (16120)
Artificial intelligence (199)
Bankruptcy (357)
Best Places to Work (11638)
Biotechnology (176)
Breast cancer (225)
Cancer (1713)
Cardiovascular disease (128)
Career advice (1669)
CAR-T (121)
Cell therapy (353)
Clinical research (65303)
Collaboration (660)
Compensation (370)
COVID-19 (2563)
C-suite (160)
Data (1629)
Diabetes (212)
Diagnostics (6283)
Earnings (85449)
Employer resources (146)
Events (110931)
Executive appointments (564)
FDA (17037)
Funding (603)
Gene therapy (245)
GLP-1 (649)
Government (4358)
Healthcare (18771)
Infectious disease (2674)
Inflammatory bowel disease (121)
Interviews (310)
IPO (16463)
Job creations (3627)
Job search strategy (1420)
Layoffs (438)
Legal (7887)
Lung cancer (255)
Manufacturing (235)
Medical device (13261)
Medtech (13266)
Mergers & acquisitions (19324)
Metabolic disorders (550)
Neuroscience (1715)
NextGen: Class of 2025 (6509)
Non-profit (4478)
Northern California (2090)
Obesity (307)
Opinion (193)
Patents (162)
People (56856)
Phase I (20346)
Phase II (28769)
Phase III (21409)
Pipeline (711)
Postmarket research (2562)
Preclinical (8591)
Radiopharmaceuticals (241)
Rare diseases (321)
Real estate (5897)
Regulatory (21926)
Research institute (2312)
Resumes & cover letters (349)
Southern California (1791)
Startups (3569)
United States (18443)
Vaccines (614)
Weight loss (209)
Date
Today (11)
Last 7 days (593)
Last 30 days (2482)
Last 365 days (34406)
2025 (4430)
2024 (35236)
2023 (40089)
2022 (51196)
2021 (55732)
2020 (54095)
2019 (46551)
2018 (35033)
2017 (32132)
2016 (31510)
2015 (37574)
2014 (31339)
2013 (26354)
2012 (28579)
2011 (29272)
2010 (27330)
Location
Africa (716)
Arizona (211)
Asia (37535)
Australia (6158)
California (4762)
Canada (1715)
China (392)
Colorado (217)
Connecticut (230)
Europe (80497)
Florida (688)
Georgia (165)
Illinois (455)
Indiana (259)
Maryland (742)
Massachusetts (3602)
Michigan (198)
Minnesota (334)
New Jersey (1347)
New York (1359)
North Carolina (833)
Northern California (2090)
Ohio (173)
Pennsylvania (1098)
South America (1093)
Southern California (1791)
Texas (701)
Utah (143)
Washington State (467)
692,820 Results for "immunotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Paradox Immunotherapeutics Appoints Sandy Zweifach as Executive Chairman
January 7, 2025
·
3 min read
Press Releases
OSE Immunotherapeutics Appoints Dr. Sonya Montgomery as Chief Development Officer
January 14, 2025
·
5 min read
Press Releases
OSE Immunotherapeutics Strengthens Leadership and Executive Committee
December 3, 2024
·
8 min read
Press Releases
OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy
January 30, 2025
·
5 min read
Press Releases
Lifordi Immunotherapeutics Appoints Matthew W. McClure, M.D., as Chief Medical Officer
January 9, 2025
·
2 min read
Business
OSE Immunotherapeutics Provides Business and Corporate Update
OSE Immunotherapeutics Provides Business and Corporate Update Three pharmaceutical agreements signed during the last three months.
May 30, 2024
·
12 min read
Press Releases
KaliVir Immunotherapeutics Announces FDA Clearance of Investigational New Drug (IND) for Oncolytic Immunotherapy VET3-TGI for Solid Tumors
KaliVir Immunotherapeutics, Inc. today announced that the FDA has cleared the Investigational New Drug (IND) application for the STEALTH-001 study of VET3-TGI in patients with incurable, advanced solid tumors.
July 1, 2024
·
2 min read
Press Releases
OSE Immunotherapeutics Presents Positive Preclinical Data on Combination of Anti-IL-7 Receptor Lusvertikimab in Chronic Colitis In Oral Presentation at 20th Congress of ECCO
February 20, 2025
·
6 min read
Press Releases
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’
July 1, 2024
·
9 min read
Press Releases
OSE Immunotherapeutics Presents Three Abstracts for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ECCO
January 28, 2025
·
4 min read
1 of 69,282
Next
